Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Dexcom

DexCom Earnings Preview: What to Expect

DexCom is scheduled to announce its fiscal third-quarter earnings later this month, and analysts project a double-digit profit rise.

Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA

Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA

Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device.

Best Bang For Your Buck? 2 Bargain Stocks with 30%+ Upside

Best Bang For Your Buck? 2 Bargain Stocks with 30%+ Upside

These two companies could present an opportunity for investors to gain access while they are relatively undervalued and before they appreciate once again.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

How Is DexCom's Performance Compared to Other Medical Device Companies?

DexCom has outperformed the broader medical devices industry over the past year, and analysts remain strongly bullish on the stock’s prospects.

DexCom, GE, SLB: Why Experts Rate These Stocks at Strong Buy

Wall Street gives these three diverse names Strong Buy recommendations with high potential upside.

DexCom Stock: Analyst Estimates & Ratings

Despite DexCom’s underwhelming price action, Wall Street analysts appear highly optimistic about its prospects.

What You Need to Know Ahead of DexCom’s Earnings Release

DexCom is all geared up to announce its second-quarter earnings towards the end of this month, and analysts anticipate a single-digit bottom-line growth.

inkl

Read news from The Economist, FT, and more,
with one subscription

2 ‘Strong Buy’ Stocks That the MAHA Movement AND Wall Street Love

2 ‘Strong Buy’ Stocks That the MAHA Movement AND Wall Street Love

Policies associated with the MAHA movement could boost these two stocks significantly.

Diabetics at Risk: FDA Issues Highest-Level Recall on 2M Dexcom Devices Over 'Deadly Fault'

Diabetics at Risk: FDA Issues Highest-Level Recall on 2M Dexcom Devices Over 'Deadly Fault'

The FDA has recalled 2 million Dexcom glucose monitors due to a serious safety risk. Learn how diabetic patients should act immediately to protect their health.

International Business Times UK

DexCom Stock: Is DXCM Underperforming the Health Care Sector?

DexCom Stock: Is DXCM Underperforming the Health Care Sector?

DexCom has underperformed the Health Care sector over the past year, but analysts are highly optimistic about the stock’s prospects.

Garmin has patented long-term blood glucose tracking; here's how it'd work

Garmin has patented long-term blood glucose tracking; here's how it'd work

Garmin watches already pair with Dexcom for indirect blood glucose monitoring. This patent shows how Garmin watches could directly help diabetics.

Android Central

Do Wall Street Analysts Like DexCom Stock?

Do Wall Street Analysts Like DexCom Stock?

Despite trailing the broader market over the past year, DexCom continues to attract strong optimism from Wall Street analysts, who maintain a highly positive outlook on the stock's long-term potential.

DexCom Stock: Earnings Beat and New Market Access Drive Bull Case

DexCom Stock: Earnings Beat and New Market Access Drive Bull Case

Dexcom's strong quarterly performance and innovative product pipeline signal continued leadership and expansion within the evolving diabetes technology market.

Oura brings AI-powered meals and glucose tracking to the US

Oura brings AI-powered meals and glucose tracking to the US

Oura launches two metabolic features within the Oura app that help users track their meals, rise in glucose levels to manage their eating habits.

Android Central

Get all your
news in one place.

100’s of premium titles.
One news app.

Is DexCom Stock Underperforming the Dow?

DexCom significantly underperformed the Dow over the past year, yet analysts remain strongly bullish on the stock’s long term prospects.

DexCom Stock Outlook: Is Wall Street Bullish or Bearish?

Although DexCom has significantly lagged behind the broader market over the past year, Wall Street analysts remain strongly optimistic about the stock's prospects.

What to Expect From DexCom's Q4 2024 Earnings Report

DexCom is gearing up to release its fourth-quarter earnings next month, and analysts forecast single-digit profit growth.

Android Central

The Oura Ring is about giving your body a voice, says Oura CEO

The Oura Ring 4 set a standard in the smart ring industry, and its CEO is excited for the future to make Oura the ring connected to our health.

Get all your
news in one place.

100’s of premium titles.
One news app.

Is DexCom Stock Underperforming the Nasdaq?

Despite DexCom's lagging performance relative to the Nasdaq Composite over the past year, Wall Street analysts maintain a strong bullish outlook on the stock's prospects.

Key Takeaways From DexCom Analyst Ratings

DexCom (NASDAQ:DXCM) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

The Stelo glucose biosensor changed the way I manage my diabetes - I tested it for two weeks, and here's how it went

The Stelo glucose biosensor is more affordable and accessible, but how well does it work for diabetics?

International Business Times

Dexcom Glucose Data To Be Integrated With ŌURA Rings

Dexcom and ŌURA have partnered to integrate Dexcom's glucose biosensing feature with the ŌURA Ring's health metrics to help improve consumers' metabolic health.

Your Oura Ring will be able to show you glucose readings in 2025 – thanks to Dexcom integration

The company is now valued at over $5 billion

Are Wall Street Analysts Predicting DexCom Stock Will Climb or Sink?

Despite DexCom’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Evening Standard

Nick Jonas wants to 'take bigger risks' as he reflects on 'wild' Jonas Brothers milestone

EXCLUSIVE The singer-songwriter and actor has crammed a lot into his 32 years of life and the ‘incredibly ambitious and driven’ star is determined there will be a lot more to come

People

Robert F. Kennedy Jr

Priyanka Chopra

The Jonas Brothers

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Android Central

Abbott Laboratories

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

311,905 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play